Many exciting biomed startups have found a home in the venture capital market. “Public investors are risk averse these days,” says VentureWire’s Tom Salemi. “They only want to bet on as sure a thing as possible. That’s not usually the ...
Tom Salemi tagged posts:
August 28th, 2006 | Connected Social Media Syndication